Get started
Author

Eli Lilly

Anatomically interpretable deep learning of brain age captures domain-specific cognitive impairment
2023 · Chenzhong Yin, Phoebe Imms, et al. · Proceedings of the National Academy of Sciences · 129
Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer’s disease pathogenesis
2018 · Xiaopu Zhou, Yu Chen, et al. · Proceedings of the National Academy of Sciences · 97
PDF
Statistical tests and identifiability conditions for pooling and analyzing multisite datasets
2018 · Hao Henry Zhou, Vikas Singh, et al. · Proceedings of the National Academy of Sciences · 38
Bayesian ADEPT assisted decision making in early phase trials
2003 · Alun Bedding, Eli Lilly · Pharmaceutical Statistics · 6
The Efficacy of Drotrecogin Alfa (activated) for the Treatment of Pediatric Severe Sepsis.
2005 · Brett Giroir, Brahm Goldstein, et al. · Critical Care Medicine · 5
Abstract 1439: Cytochrome P450 Genetic Variants Predict Cardiovascular Outcomes following Treatment with Clopidogrel but not with Prasugrel
2008 · Jessica L Mega, Lei Shen, et al. · Circulation · 4
Bayesian approaches to clinical trials and health‐care evaluation Spiegelhalter DJ, Abrams KR, Myles JP (2004) ISBN 0471499757; 406 pages; £45.00, 67.50, $85.00 Wiley; http://www.wileyeurope.com/WileyCDA/WileyTitle/productCd‐0471499757.html
2004 · Alun Bedding, Eli Lilly · Pharmaceutical Statistics · 3
Coagulopathy May Occur Before the Clinical Diagnosis of Organ Dysfunction
2002 · William Macias, Philip A Derchak, et al. · Critical Care Medicine · 3
Hospital and Follow-up Costs in a Severe Sepsis Managed Care Population
2002 · LeeAnn Braun, Liesl M Cooper, et al. · Critical Care Medicine · 3
Effects of X Irradiation on Cholesterol, Fatty Acid and Protein Synthesis
1957 · R. Gordon Gould, Vernon L. Bell, et al. · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · 3
Changes in Markers of Coagulation and Inflammation in Patients With Pediatric Severe Sepsis Treated With Drotrecogin Alfa (activated).
2005 · Simon Nadel, Mark D Williams, et al. · Critical Care Medicine · 2
Racial Variation in the Incidence, Icu Utilization, and Mortality of Severe Sepsis
2004 · Sherri L Alexander, Eli Lilly, et al. · Critical Care Medicine · 2
13. Assessment of Severe Sepsis in Children: Experiences from Pediatric Patients Receiving Drotrecogin Alfa (Activated)
2004 · Virginia L. Wyss, Jane Cunneen, et al. · Journal of Emergency Nursing · 2
PDF
Reduction of psychotic symptoms in patients with lewy body-like symptoms treated with olanzapine
2000 · W. Scott Clark, Eli Lilly, et al. · Neurobiology of Aging · 2
Resource Use Variation Among Severe Sepsis Patients Treated With Drotrecogin Alfa (activated) in the Xeus Study
2004 · Walter Linde-Zwirble, Frank R Ernst, et al. · Critical Care Medicine · 1
Pe1 Assessing Effectiveness in the Presence of Treatment Switching: Data From an Effectiveness Study of Antipsychotics
2004 · D Faries, A Nyhuis, et al. · Value in Health · 1
2105 UCSF AutoImmunoProfiler – Understanding the Immunomes of Autoimmune diseases
2022 · Eli Lilly, led by UCSF leadership team of David Erle, et al. · Lupus Science & Medicine
PDF
P1‐298: Characterization of novel apoE isoform‐dependent C‐terminal specific proteolysis of Aβ1‐42 by microglia
2010 · Feng Liu, Suizhen Lin, et al. · Alzheimer s & Dementia
893: The Role of Noradrenergic Pathways in Sneeze-Induced Urethral Continence Reflex in Rats
2006 · Yasuhiro Kaiho, Izumi Kama, et al. · The Journal of Urology
Baseline Characteristics of Patients Enrolled in Resolve: a Phase Iii Trial of Drotrecogin Alfa (activated) in Pediatric Severe Sepsis.
2005 · Shamel Abd-Allah, Brad Woodward, et al. · Critical Care Medicine
Decision making in health and medicineHunink M, Glasziou P, Siegel J, Weeks J, Pliskin J, Elstein A, Weinstein MC (2001)ISBN 0521770297; 404 pages; £38; $60Cambridge University Press; http://uk.cambridge.org/catalogue/catalogue.asp?isbn=0521770297
2005 · Alun Bedding, Eli Lilly · Pharmaceutical Statistics
1116-31 Induction of marked changes in serum lipids and apolipoprotein A-1 expression in human Apo A-1 transgenic mice by a novel peroxisome proliferator-activated receptor alpha agonist LY518674
2004 · Jai Pal Singh, Raymond Kauffman, et al. · Journal of the American College of Cardiology
PDF
The role of alpha-1-antichymotrypsin (ACT) in abeta-amyloidosis of Alzheimer's disease, as studied in novel trigenic PDAPP, mapoe-knockout, GFAP-hACT transgenic mice strains
2000 · Lars Ng Nilsson, Giovanni DiCarlo, et al. · Neurobiology of Aging
Modern Pharmaceutical Manufacturing1
1927 · Eli Lilly · Industrial & Engineering Chemistry
Works count: 24
Citation count: 301
H-index: 5
I10-index: 3
Year
Topic
Type